Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
New members elected to Occlutech Board of Directors 2021-05-03 15:00
Ultrahuman Launches Mac App, Trends on #1 on App Store 2021-05-03 08:55
Asclepius Meditec's Hydrogen Oxygen Generator with Nebulizer is Expected to Alleviate the Oxygen Shortage Crisis during COVID-19 Pandemic 2021-05-01 17:17
New focus on COVID-19 infection and the future of human reproduction 2021-05-01 13:00
Tessa Therapeutics Announces Enrollment of 12 Patient Pilot Cohort in its Relapsed or Refractory Hodgkin Lymphoma Phase 2 Study 2021-04-30 18:00
BioVaxys Broadens Intellectual Property Portfolio Commercial Trademark Application Filed for CoviDTH(R) Diagnostic 2021-04-29 20:56
Artificial Intelligence helps IVF patients avoid invasive embryo genetic testing 2021-04-29 19:47
2021, a turning point for PQE Group: no more internal hierarchy and a hiring plan of 550 new employees 2021-04-29 18:18
Hilco Industrial Acquires All Machinery & Equipment from Legacy Pharmaceutical Switzerland 2021-04-29 13:04
Antengene Announces XPO1 Inhibitor Selinexor Prescribed for the First Time in the Pilot Zone of Hainan Province and Authorized to be Expanded Beyond the Pilot Zone for Outpatient Treatment 2021-04-29 08:34
Alphamab announced PD-L1/CTLA-4 bispecific antibody KN046 will enter new Phase II clinical trial in combination with Pfizer's Inlyta® (axitinib) 2021-04-29 08:00
Innovent Announces First Patient Dosed in the Phase 2 Clinical Trial of IBI302, a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for Neovascular Age-Related Macular Degeneration 2021-04-29 08:00
Essence Group Announces 'Peace of Mind' Strategy as Top Objective of All Future IoT Products and Services 2021-04-29 07:01
AnchorDx Jointly Publishes Clinical Research Paper: "Accurate Diagnosis of Pulmonary Nodules Using a Non-invasive DNA Methylation Test" 2021-04-28 21:00
CROs dMed and Clinipace Merge to Accelerate Customer Success 2021-04-28 20:00
Novaliq Announces More than 50% Patients Enrolled in CyclASol® Phase 3 Dry Eye Disease Trial ESSENCE-2 2021-04-28 20:00
ERT and Bioclinica Close Merger, Creating the Global Leader in Clinical Trial Endpoint Technology 2021-04-28 19:59
Turn Biotechnologies completes latest round of funding 2021-04-28 19:50
Ascensia Rolls Out The On@Pro Online Educational Platform for Healthcare Professionals in Collaboration With the Tumaini Institute 2021-04-28 15:00
Genesis MedTech to Introduce Revolutionary Laparoscopic Technology to China and Singapore 2021-04-28 10:01
1 250 251 252 253 254 491